Developer docs
API playgroundTry for free, no card

Search company profiles

SmithRx

Full company profile

uuid0000a28

Namestring
SmithRx
Legal namestring
Smith Health, Inc.
Websiteurl
smithrx.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

SmithRx is a privately held, modern pharmacy benefit manager (PBM) founded in 2016 and headquartered in San Francisco, with additional engineering operations in Lehi, UT, and a Plano, TX office. The company serves more than 5,000 self-insured employer clients across 36 states, delivering pharmacy benefits to hundreds of thousands of members through an 85,000+ pharmacy network. SmithRx sells primarily through benefits brokers and consultants and competes directly against vertically integrated legacy PBMs that control approximately 80% of the U.S. prescription drug market.

The company's core product is the SmithRx Modern PBM Platform, which operates on a 100% pass-through pricing model: clients pay exactly what pharmacies are reimbursed, plus a flat per-member-per-month (PMPM) administrative fee that is fully decoupled from drug spend. SmithRx retains no rebates, charges no spread pricing, and has no ownership interest in pharmacies or manufacturers. The platform is differentiated by the proprietary Drug Pathways Engine, which continuously identifies lowest-net-cost medication pathways, and by the Connect 360 cost-containment suite, which activates coupons, manufacturer assistance programs, and alternative sourcing (including a partnership with Mark Cuban Cost Plus Drugs). Average PMPM cost is more than 20% below legacy PBM benchmarks, with case-study clients reporting PMPM as low as $39 versus the $112 industry average.

SmithRx generates revenue exclusively through fixed monthly administrative fees per member. Its go-to-market is enterprise field sales supported by a broker channel (Brown & Brown, Hotchkiss Insurance, Intrepid Benefits, The Daniel & Henry Company) and content-led demand generation via the SmithRx blog, Full Disclosure webinar series, and PBM Evaluation Guide. The company has raised approximately $80 million across multiple venture rounds, with Venrock leading both the $20M Series B (March 2022) and $60M Series C (January 2024). SmithRx is among the first 25 PBMs to earn URAC Pharmacy Benefit Management Accreditation (valid through February 2029) and is a founding member of Transparency-Rx, a federal PBM reform coalition.

Short descriptiontext

SmithRx is a modern pharmacy benefit manager serving 5,000+ self-insured employers across 36 states via a 100% pass-through pricing model with flat PMPM admin fees. The proprietary Drug Pathways Engine and Connect 360 programs deliver 20%+ drug-cost savings versus legacy PBMs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy benefit management, transparent PBM services, pass-through drug pricing, pharmacy benefits administration, prescription cost management
Industry5 codes
PRIMARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAEAKAD
Manufacturer Contracting, Rebates & Revenue Management
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLAEAKAA
Formulary Management & Clinical Pharmacy Programs
SECONDARYHLAEAKAI
Copay Assistance, Patient Support & Affordability Programs
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Hospital & Medical Service Plans6324
Product category
Pharmacy Benefit Management
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Administrative Fees (PMPM)
TypeSubscription Recurring
Description

SmithRx charges a flat administrative fee per member per month (PMPM) as its primary revenue source. This fee structure is decoupled from drug spend, ensuring the company's incentives are aligned with reducing drug costs for clients rather than maximizing medication spend. Average PMPM cost for clients is more than 20% below industry averages.

smithrx.com
2Pass-Through Drug Revenue
TypeManaged Services
Description

100% of rebates and discounts from manufacturers are passed through to plan sponsors. SmithRx does not take economics from the supply chain, does not retain rebates, and does not engage in spread pricing. The company makes no revenue from drug ingredient costs.

smithrx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Flat Administrative Fee Model
ModelSubscriptionBilling cadenceMonthly
Notes

Fixed administrative fee per member per month (PMPM), completely decoupled from drug spend or volume. Revenue comes solely from flat monthly fees, not from medication costs. No arbitrary markups, no retained rebates, zero hidden fees.

smithrx.com
2Pass-Through Pricing
ModelOtherBilling cadenceMonthly
Notes

Plan sponsor pays exactly what the pharmacy is paid, plus the transparent fixed administrative fee. 100% of rebates passed back to the plan. No spread pricing.

smithrx.com
3Platform-Based Cost Model
ModelOtherBilling cadenceMonthly
Notes

Drug ingredient costs passed through at acquisition cost plus fixed dispensing fee. Total PMPM = Admin Fees + Drug Costs / Number of Members x Number of Months.

smithrx.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SmithRx is a modern pharmacy benefit manager (PBM) that delivers 100% pass-through pharmacy benefits to self-insured employers, eliminating spread pricing and rebate retention. The company charges a flat per-member-per-month (PMPM) administrative fee decoupled from drug spend, while passing all manufacturer rebates and discounts back to plan sponsors. Its platform combines the proprietary Drug Pathways Engine, Connect 360 cost-containment programs, and transparent claims-level reporting to achieve 20%+ savings versus legacy PBMs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 20%+ savings on total drug costs vs legacy PBMs
+5 more records
Product overview1 text field

SmithRx offers a modern pharmacy benefit management (PBM) platform built on radical transparency and fiduciary alignment. The core offering is the SmithRx Modern PBM Platform, which operates on a 100% pass-through model delivering actual contracted pharmacy rates without spread pricing or hidden fees. This platform is enhanced by the Connect 360 cost-containment module (covering coupons, manufacturer savings, and assistance programs), the proprietary Drug Pathways Engine for savings optimization, and the Find My Meds member cost-comparison tool. The architecture decouples drug ingredient costs from dispensing fees to surface true market pricing to employers, with an average PMPM cost more than 20% below industry averages.

Product and service2 records
1SmithRx Modern PBM Platform
CategoryPharmacy Benefit Management (Core Platform)
Description

A radically transparent pharmacy benefit management platform providing 100% pass-through pricing, fiduciary-aligned services, and technology-powered member experience for self-insured employers. The platform delivers real-time cost visibility, claims-level data access, audit rights, and white-glove service, with PMPM costs averaging 20%+ below industry averages.

2Connect 360
CategoryPharmacy Cost-Containment Program
Description

A suite of cost-containment programs including coupon application, manufacturers' savings programs, patient assistance programs, and drug company partnerships. Connect 360 identifies lowest-cost medication pathways and provides hands-on member support for enrollment and savings realization, with reported results such as 75% increase in savings between 2022-2024 for Encore Enterprises and 57x ROI within 6 months for AgXplore.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Part of SmithRx's best-in-class partner ecosystem for GLP-1 and weight management programs. 9amHealth specializes in obesity medicine and weight management, helping employers deliver sustainable GLP-1 coverage leveraging manufacturer-approved cash-pay pricing.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Part of SmithRx's GLP-1 partner ecosystem. Calibrate provides specialized obesity medicine and weight management programs integrated with SmithRx's transparent PBM model to help employers achieve sustainable GLP-1 coverage.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Part of SmithRx's GLP-1 partner ecosystem offering specialized obesity medicine and weight management services to support employers in delivering sustainable GLP-1 coverage.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Part of SmithRx's GLP-1 partner ecosystem providing specialized obesity medicine and weight management programs to help employers deliver clinically appropriate and cost-effective GLP-1 coverage.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-09
Description

Through partnership with Mark Cuban Cost Plus Drug Company, SmithRx announced $9.5 million in client savings through innovative autoimmune drug sourcing. The partnership leverages Cost Plus Drugs' transparent cost-plus pricing model (manufacturer cost plus 15% markup plus $3 fee). Some employers achieved up to 70% in cost savings.

6Transparency-Rx
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

SmithRx is a founding member of Transparency-Rx, a lobbying coalition advocating for industry reforms targeting prescription drug costs. The coalition pushes for PBM reform and greater transparency in the pharmaceutical supply chain.

smithrx.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

CVS Caremark is the largest U.S. PBM and part of CVS Health, controlling a substantial share of the prescription drug market. It represents the incumbent model that transparent PBMs like SmithRx are displacing, with vertically integrated pharmacy and insurance operations.

TypeOthers
Description

Cost Plus Drugs is a SmithRx partner that disrupts drug pricing through transparent cost-plus markup. It is both a distribution partner for autoimmune drug sourcing and an adjacent industry disruptor aligned with SmithRx's transparency mission.

TypeBroad incumbent
Description

OptumRx is the PBM arm of UnitedHealth Group and one of the three dominant legacy PBMs. It represents the vertically integrated incumbent that transparent PBMs like SmithRx compete against for self-insured employer accounts.

TypeBroad incumbent
Description

Express Scripts is one of the three largest U.S. PBMs, owned by Cigna, and represents the legacy PBM model that SmithRx's pass-through positioning is designed to displace. It offers broad formulary management and mail-order pharmacy capabilities.

TypeEmerging player
Description

AffirmedRx is an emerging transparent PBM serving self-insured employers with a 100% pass-through model. As a newer entrant in the same transparency-focused category, it competes for similar employer clients seeking fiduciary-aligned PBM services.

TypeDirect peer
Description

Liviniti (formerly known as LDI Integrated Pharmacy Services) is a transparent PBM serving self-funded employers with pass-through pricing and customized clinical programs. The companies compete head-to-head for the same self-insured employer segment.

TypeDirect peer
Description

Capital Rx is a direct transparent PBM competitor offering a technology-driven, pass-through model with no spread pricing and full rebate pass-through to plan sponsors. Both companies target self-insured employers with claims-level transparency and technology-led cost optimization.

TypeDirect peer
Description

Navitus is a transparent, pass-through PBM serving employer-sponsored and health plan clients. Both companies share the 100% pass-through model with no rebate retention and emphasize client-aligned cost savings versus legacy PBM economics.

9RxBenefits
TypeDirect peer
Description

RxBenefits provides pharmacy benefit management services to mid-market employers primarily through benefits brokers. Like SmithRx, RxBenefits leverages the broker channel and focuses on transparent contracting for self-insured employer plans.

TypeDirect peer
Description

EmpiRx Health is a transparent PBM offering pass-through pricing and clinical management services to self-insured employers and labor unions. Both companies target the same segment with a similar transparency-focused value proposition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SmithRx

Pharmacy Benefit Managementsmithrx.com

SmithRx is a modern pharmacy benefit manager serving 5,000+ self-insured employers across 36 states via a 100% pass-through pricing model with flat PMPM admin fees. The proprietary Drug Pathways Engine and Connect 360 programs deliver 20%+ drug-cost savings versus legacy PBMs.

What SmithRx does

SmithRx is a privately held, modern pharmacy benefit manager (PBM) founded in 2016 and headquartered in San Francisco, with additional engineering operations in Lehi, UT, and a Plano, TX office. The company serves more than 5,000 self-insured employer clients across 36 states, delivering pharmacy benefits to hundreds of thousands of members through an 85,000+ pharmacy network. SmithRx sells primarily through benefits brokers and consultants and competes directly against vertically integrated legacy PBMs that control approximately 80% of the U.S. prescription drug market.

The company's core product is the SmithRx Modern PBM Platform, which operates on a 100% pass-through pricing model: clients pay exactly what pharmacies are reimbursed, plus a flat per-member-per-month (PMPM) administrative fee that is fully decoupled from drug spend. SmithRx retains no rebates, charges no spread pricing, and has no ownership interest in pharmacies or manufacturers. The platform is differentiated by the proprietary Drug Pathways Engine, which continuously identifies lowest-net-cost medication pathways, and by the Connect 360 cost-containment suite, which activates coupons, manufacturer assistance programs, and alternative sourcing (including a partnership with Mark Cuban Cost Plus Drugs). Average PMPM cost is more than 20% below legacy PBM benchmarks, with case-study clients reporting PMPM as low as $39 versus the $112 industry average.

SmithRx generates revenue exclusively through fixed monthly administrative fees per member. Its go-to-market is enterprise field sales supported by a broker channel (Brown & Brown, Hotchkiss Insurance, Intrepid Benefits, The Daniel & Henry Company) and content-led demand generation via the SmithRx blog, Full Disclosure webinar series, and PBM Evaluation Guide. The company has raised approximately $80 million across multiple venture rounds, with Venrock leading both the $20M Series B (March 2022) and $60M Series C (January 2024). SmithRx is among the first 25 PBMs to earn URAC Pharmacy Benefit Management Accreditation (valid through February 2029) and is a founding member of Transparency-Rx, a federal PBM reform coalition.

SmithRx firmographics

Firmographics
Name
SmithRx
Legal name
Smith Health, Inc.
Website
https://smithrx.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
501–1,000 employees
Short description
SmithRx is a modern pharmacy benefit manager serving 5,000+ self-insured employers across 36 states via a 100% pass-through pricing model with flat PMPM admin fees. The proprietary Drug Pathways Engine and Connect 360 programs deliver 20%+ drug-cost savings versus legacy PBMs.
Ownership category
akta.pro rank

SmithRx industry classification

Industry
Product category
Pharmacy Benefit Management
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Hospital & Medical Service Plans (6324)
akta.pro industry
PRIMARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAEAKAD
Manufacturer Contracting, Rebates & Revenue Management
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLAEAKAA
Formulary Management & Clinical Pharmacy Programs
SECONDARYHLAEAKAI
Copay Assistance, Patient Support & Affordability Programs

Keywords

  • Pharmacy benefit management
  • Transparent PBM services
  • Pass-through drug pricing
  • Pharmacy benefits administration
  • Prescription cost management

Where SmithRx is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

SmithRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Administrative Fees (PMPM): SmithRx charges a flat administrative fee per member per month (PMPM) as its primary revenue source. This fee structure is decoupled from drug spend, ensuring the company's incentives are aligned with reducing drug costs for clients rather than maximizing medication spend. Average PMPM cost for clients is more than 20% below industry averages.
  2. Pass-Through Drug Revenue: 100% of rebates and discounts from manufacturers are passed through to plan sponsors. SmithRx does not take economics from the supply chain, does not retain rebates, and does not engage in spread pricing. The company makes no revenue from drug ingredient costs.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyFlat Administrative Fee Model
OtherMonthlyPass-Through Pricing
OtherMonthlyPlatform-Based Cost Model

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

SmithRx product offering

Product offering

Core offering

SmithRx is a modern pharmacy benefit manager (PBM) that delivers 100% pass-through pharmacy benefits to self-insured employers, eliminating spread pricing and rebate retention. The company charges a flat per-member-per-month (PMPM) administrative fee decoupled from drug spend, while passing all manufacturer rebates and discounts back to plan sponsors. Its platform combines the proprietary Drug Pathways Engine, Connect 360 cost-containment programs, and transparent claims-level reporting to achieve 20%+ savings versus legacy PBMs.

Product overview

SmithRx offers a modern pharmacy benefit management (PBM) platform built on radical transparency and fiduciary alignment. The core offering is the SmithRx Modern PBM Platform, which operates on a 100% pass-through model delivering actual contracted pharmacy rates without spread pricing or hidden fees. This platform is enhanced by the Connect 360 cost-containment module (covering coupons, manufacturer savings, and assistance programs), the proprietary Drug Pathways Engine for savings optimization, and the Find My Meds member cost-comparison tool. The architecture decouples drug ingredient costs from dispensing fees to surface true market pricing to employers, with an average PMPM cost more than 20% below industry averages.

Differentiator

Problem solved

Functional benefit

Products and services

  • SmithRx Modern PBM Platform A radically transparent pharmacy benefit management platform providing 100% pass-through pricing, fiduciary-aligned services, and technology-powered member experience for self-insured employers. The platform delivers real-time cost visibility, claims-level data access, audit rights, and white-glove service, with PMPM costs averaging 20%+ below industry averages.
  • Connect 360 A suite of cost-containment programs including coupon application, manufacturers' savings programs, patient assistance programs, and drug company partnerships. Connect 360 identifies lowest-cost medication pathways and provides hands-on member support for enrollment and savings realization, with reported results such as 75% increase in savings between 2022-2024 for Encore Enterprises and 57x ROI within 6 months for AgXplore.

Quantifiable outcome

  • 20%+ savings on total drug costs vs legacy PBMs
  • +5 more outcomes

Companies that use SmithRx

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

SmithRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

SmithRx partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and flagship.

  • 9amHealthcoreStrategic or Co-development Partner · 9 June 2026Part of SmithRx's best-in-class partner ecosystem for GLP-1 and weight management programs. 9amHealth specializes in obesity medicine and weight management, helping employers deliver sustainable GLP-1 coverage leveraging manufacturer-approved cash-pay pricing.
  • CalibratecoreStrategic or Co-development Partner · 9 June 2026Part of SmithRx's GLP-1 partner ecosystem. Calibrate provides specialized obesity medicine and weight management programs integrated with SmithRx's transparent PBM model to help employers achieve sustainable GLP-1 coverage.
  • FlyteHealthcoreStrategic or Co-development Partner · 9 June 2026Part of SmithRx's GLP-1 partner ecosystem offering specialized obesity medicine and weight management services to support employers in delivering sustainable GLP-1 coverage.
  • Form HealthcoreStrategic or Co-development Partner · 9 June 2026Part of SmithRx's GLP-1 partner ecosystem providing specialized obesity medicine and weight management programs to help employers deliver clinically appropriate and cost-effective GLP-1 coverage.
  • Mark Cuban Cost Plus Drugs CompanycoreStrategic or Co-development Partner · 9 June 2026Through partnership with Mark Cuban Cost Plus Drug Company, SmithRx announced $9.5 million in client savings through innovative autoimmune drug sourcing. The partnership leverages Cost Plus Drugs' transparent cost-plus pricing model (manufacturer cost plus 15% markup plus $3 fee). Some employers achieved up to 70% in cost savings.
  • Transparency-RxflagshipStrategic or Co-development PartnerSmithRx is a founding member of Transparency-Rx, a lobbying coalition advocating for industry reforms targeting prescription drug costs. The coalition pushes for PBM reform and greater transparency in the pharmaceutical supply chain.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

SmithRx competitors and assessment

Company assessment

Broad incumbents

  • CVS Caremark: CVS Caremark is the largest U.S. PBM and part of CVS Health, controlling a substantial share of the prescription drug market. It represents the incumbent model that transparent PBMs like SmithRx are displacing, with vertically integrated pharmacy and insurance operations.
  • OptumRx: OptumRx is the PBM arm of UnitedHealth Group and one of the three dominant legacy PBMs. It represents the vertically integrated incumbent that transparent PBMs like SmithRx compete against for self-insured employer accounts.
  • Express Scripts: Express Scripts is one of the three largest U.S. PBMs, owned by Cigna, and represents the legacy PBM model that SmithRx's pass-through positioning is designed to displace. It offers broad formulary management and mail-order pharmacy capabilities.

Others

  • Mark Cuban Cost Plus Drug Company: Cost Plus Drugs is a SmithRx partner that disrupts drug pricing through transparent cost-plus markup. It is both a distribution partner for autoimmune drug sourcing and an adjacent industry disruptor aligned with SmithRx's transparency mission.

Emerging players

  • AffirmedRx: AffirmedRx is an emerging transparent PBM serving self-insured employers with a 100% pass-through model. As a newer entrant in the same transparency-focused category, it competes for similar employer clients seeking fiduciary-aligned PBM services.

Direct peers

  • Liviniti: Liviniti (formerly known as LDI Integrated Pharmacy Services) is a transparent PBM serving self-funded employers with pass-through pricing and customized clinical programs. The companies compete head-to-head for the same self-insured employer segment.
  • Capital Rx: Capital Rx is a direct transparent PBM competitor offering a technology-driven, pass-through model with no spread pricing and full rebate pass-through to plan sponsors. Both companies target self-insured employers with claims-level transparency and technology-led cost optimization.
  • Navitus Health Solutions: Navitus is a transparent, pass-through PBM serving employer-sponsored and health plan clients. Both companies share the 100% pass-through model with no rebate retention and emphasize client-aligned cost savings versus legacy PBM economics.
  • RxBenefits: RxBenefits provides pharmacy benefit management services to mid-market employers primarily through benefits brokers. Like SmithRx, RxBenefits leverages the broker channel and focuses on transparent contracting for self-insured employer plans.
  • EmpiRx Health: EmpiRx Health is a transparent PBM offering pass-through pricing and clinical management services to self-insured employers and labor unions. Both companies target the same segment with a similar transparency-focused value proposition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

SmithRx social profiles

Digital presence

SmithRx compliance and trust

Trust signal

Compliance1 record

SmithRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SmithRx leadership team

Management profile

Number of profiles

Profiles10 records

SmithRx funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SmithRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SmithRx

What does SmithRx do?

SmithRx is a modern pharmacy benefit manager (PBM) that delivers 100% pass-through pharmacy benefits to self-insured employers, eliminating spread pricing and rebate retention. The company charges a flat per-member-per-month (PMPM) administrative fee decoupled from drug spend, while passing all manufacturer rebates and discounts back to plan sponsors. Its platform combines the proprietary Drug Pathways Engine, Connect 360 cost-containment programs, and transparent claims-level reporting to achieve 20%+ savings versus legacy PBMs.

Is SmithRx a public or private company?

SmithRx is a private company. It is classified as venture growth investor backed and is currently operating.

When was SmithRx founded?

SmithRx was founded in 2016. It employs 501 to 1,000 people.

Where is SmithRx based?

SmithRx is headquartered in San Francisco, United States, in the North America region.

How does SmithRx make money?

Two revenue lines are on record. Administrative Fees (PMPM) is the primary driver. The others are pass-Through Drug Revenue.

Who are SmithRx's main competitors?

Broad incumbents on record are CVS Caremark, OptumRx and Express Scripts. Mark Cuban Cost Plus Drug Company is listed as an others. AffirmedRx is listed as an emerging player. Direct peers are Liviniti, Capital Rx, Navitus Health Solutions, RxBenefits and EmpiRx Health.

Does SmithRx have an API?

No public API is recorded for SmithRx.

What industry is SmithRx in?

SmithRx's product category is Pharmacy Benefit Management. Its primary akta.pro industry code is HLAFALAI, Pharmacy Benefit Management (PBM) & Pharmacy Network Administration, with a secondary code of HLAEAKAD, Manufacturer Contracting, Rebates & Revenue Management. Its NAICS code is 524292 and its SIC code is 6324.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Managed Healthcare ExecutiveSmithRx is first PBM to Offer Humira Biosimilar YusimrySmithRx has become the first pharmacy benefit manager to offer the Humira biosimilar Yusimry through Mark Cuban Cost Plus Drug Company for $569.27, allowing members to apply insurance benefits. Coherus Biosciences is launching the drug with a list price of $995 per carton, representing an 85% discount compared to Humira's list price. This move provides a low-cost alternative for employers who often face high drug expenses for Humira.PR NewswireSmithRx Brings Prescription Drug Cost Intelligence Into Benefits Navigation Through Transcarent PartnershipSmithRx, a modern pharmacy benefits manager (PBM), announced an integration with Transcarent that brings its prescription drug cost intelligence and execution model into Transcarent's AI-powered WayFinding health navigation platform. The integration enables employees to access real-time prescription cost estimates, side-by-side pharmacy comparisons, and lower-cost alternatives while giving employers visibility into drug spend before claims are filed. SmithRx has reported average pharmacy benefit savings of more than 20% and average per member per month savings of $37 across its client base, with individual results varying by group, population, and utilization.PR NewswireSmithRx Launches Best-in-Class Partner Ecosystem to Help Employers Deliver Sustainable and Clinically Appropriate GLP-1 Programs at ScaleSmithRx, a modern pharmacy benefits manager, launched a best-in-class partner ecosystem with specialized obesity medicine and weight management providers including 9amHealth, Calibrate, Mark Cuban Cost Plus Drugs, FlyteHealth, and Form Health to help employers deliver sustainable GLP-1 coverage. The ecosystem leverages manufacturer-approved cash-pay pricing and a transparent, 100% pass-through PBM model, with some employers achieving up to 70% in cost savings. The launch responds to growing financial strain on employers from high GLP-1 drug costs and higher-than-expected utilization, with survey data showing that a meaningful portion of employers are uncertain about maintaining GLP-1 coverage in 2027.SmithrxHow Platform Pricing Aligns Modern PBM Incentives with EmployersSmithRx, a pharmacy benefit manager, has published an article outlining its platform-based pricing model that decouples drug ingredient costs from dispensing fees to surface true market pricing to employers. The article claims SmithRx's average PMPM cost is more than 20% below industry averages and argues this model eliminates hidden margins by reimbursing pharmacies at acquisition cost plus a fixed fee. The author, SmithRx's Chief Strategy Officer, positions this approach as a solution to perceived dysfunction in legacy PBM pricing practices.Business Wire BlogTranscarent Expands WayFinding™ Platform with SmithRx to Offer More Options for Pharmacy Pricing Transparency and Lower Drug Costs to EmployersTranscarent has expanded its WayFinding platform by integrating SmithRx, a pharmacy benefits management company, to provide employers and members with greater pharmacy pricing transparency. This partnership aims to lower drug costs through real-time, AI-powered guidance that identifies the lowest-cost medication options and passes 100% of rebates directly to employers.PR NewswireSmithRx Earns URAC Accreditation in Pharmacy Benefit Management, Signifying the Modern PBM Meets Industry Gold-StandardSmithRx, a modern pharmacy benefits manager, announced it has earned URAC's Pharmacy Benefit Management Accreditation, becoming among the first 25 PBMs to receive this designation. The accreditation validates SmithRx's transparency-focused business model after URAC conducted a rigorous end-to-end evaluation of its governance, clinical oversight, and operational integrity. The company serves over 5,000 employer clients and achieved more than $320 million in savings for clients in 2025.Business Wire BlogSmithRx Awarded Modern Healthcare’s Best in Business for Second Consecutive YearSmithRx was recognized by Modern Healthcare as one of the Best in Business of 2025 for the second consecutive year, honored for excellence in growth, employee engagement, and transformative solutions. The company reported partnering with over 5,000 employer clients to achieve more than $300 million in savings, reducing pharmacy benefit costs by an average of 20%. This recognition highlights SmithRx's ongoing efforts to challenge legacy pharmacy benefits models through its transparent, technology-driven platform.SmithrxProve Pharmacy Benefit ROI to Your CFOThe article discusses how HR leaders can effectively demonstrate the return on investment (ROI) of their pharmacy benefits program to CFOs, emphasizing the need for measurable financial metrics. Key metrics include per member per month costs, program-specific savings, and rebate transparency, which aid in highlighting the financial impact of the program. The SmithRx Partner Portal is presented as a valuable tool for reporting and analysis, helping HR leaders provide clear insights to their finance teams.Business Wire BlogSmithRx Named to Modern Healthcare’s Best Places to Work in Healthcare in 2025 ListSmithRx has been named to Modern Healthcare’s 2025 Best Places to Work in Healthcare list, a recognition based on employee feedback regarding culture and growth opportunities. The pharmacy benefits manager highlighted its rapid expansion, noting a 450% increase in headcount over the past three years and serving over 4,000 clients.Business Wire BlogSmithRx Unveils 2024 Growth Momentum, Reducing Pharmacy Benefit Costs by an Average of 30%SmithRx published a 2024 performance report highlighting its growth to over 4,000 employer clients and the achievement of $200 million in client savings through its Connect 360 cost-saving programs. The company reported an average reduction in pharmacy benefit costs of 30% per member per month, driven by strategies such as transitioning claims to biosimilars and utilizing generic alternatives for high-cost medications. These results underscore SmithRx's transparent, pass-through pricing model which eliminates hidden fees and rebates.